Revolutionary, Down-to-earth, Out-of-the-box... decide for yourself... the boundless energy in me keeps me busy innovating...!
Monday, May 19, 2014
Searching For A Follow-Up Act, Samsung Turns To Drugs
Samsung has set up a biotech subsidiary that is starting to produce biosimilars, or follow-on versions of expensive biotech drugs that are facing expiring patents.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.